Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
Osteoporos Int
.
2015 Nov;26(11):2721.
doi: 10.1007/s00198-015-3274-z.
Authors
H G Bone
1
2
,
D W Dempster
3
,
J A Eisman
4
,
S L Greenspan
5
,
M R McClung
6
,
T Nakamura
7
,
S Papapoulos
8
,
W J Shih
9
,
A Rybak-Feiglin
10
,
A C Santora
10
,
N Verbruggen
10
,
A T Leung
10
,
A Lombardi
10
Affiliations
1
Michigan Bone & Mineral Clinic, Detroit, MI, USA.
[email protected]
.
2
The Osteoporosis Center at St. Luke's Hospital, Chesterfield, MO, USA.
[email protected]
.
3
Columbia University, New York, NY, USA.
4
Garvan Institute of Medical Research, University of Notre Dame Australia, St Vincent's Hospital and UNSW Australia, Sydney, Australia.
5
University of Pittsburgh, Pittsburgh, PA, USA.
6
Oregon Osteoporosis Center, Portland, OR, USA.
7
University of Occupational and Environmental Health, Kitakyushu, Japan.
8
Leiden University Medical Center, Leiden, Netherlands.
9
Robert Wood Johnson Medical School, Piscataway, NJ, USA.
10
Merck Sharp and Dohme Corp., Whitehouse Station, NJ, USA.
PMID:
26359183
PMCID:
PMC4713920
DOI:
10.1007/s00198-015-3274-z
No abstract available
Publication types
Published Erratum
Grants and funding
P30 AG024827/AG/NIA NIH HHS/United States